Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non–Small-Cell Lung CancerKoji Haratani, Kazuhiko Nakagawa, Hiroyasu Kaneda et al.|JAMA Oncology|2017Cited by 1k
Peripheral Blood Biomarkers Associated with Clinical Outcome in Non–Small Cell Lung Cancer Patients Treated with NivolumabJunko Tanizaki, Kazuhiko Nakagawa, Koji Haratani et al.|Journal of Thoracic Oncology|2017Cited by 227
B7-H3 Negatively Modulates CTL-Mediated Cancer ImmunityKimio Yonesaka, Kazuhiko Nakagawa, Koji Haratani et al.|Clinical Cancer Research|2018Cited by 169